Martin T L, Kim M, Malarkey W B
J Clin Endocrinol Metab. 1985 May;60(5):855-8. doi: 10.1210/jcem-60-5-855.
Idiopathic hyperprolactinemia (IH) can be defined as the presence of elevated serum PRL levels in a patient in the absence of demonstrable pituitary or central nervous system disease and of any other recognized cause of increased PRL secretion. This study examined the long term clinical outcome of 41 patients (mean age, 26 yr) with IH followed for up to 11 yr (mean, 5.5 yr). Initial and final PRL levels were determined by RIA in the same laboratory. A correction factor was used to obviate periodic changes in the potency of the NIH standards used in the PRL assay, so that all results are expressed in terms of the original VLS no. 1 standard. The initial serum PRL levels ranged from 27.2-243 ng/ml, with a mean of 57 ng/ml. Only three patients had initial serum PRL levels greater than 100 ng/ml. All had a normal skull x-ray and/or brain computed tomographic scan during their initial visit. All 41 patients had galactorrhea and/or amenorrhea. Serum PRL levels remained the same, decreased, or returned to normal in 34 of 41 patients. The mean PRL level at the time of reevaluation was 35 ng/ml. Thirty-four percent of the patients had a normal serum PRL level. Only 17% of the patients had serum PRL levels that were significantly higher (greater than 50% of their original value). Six of 9 patients with an initial serum PRL level less than 40 ng/ml had normal levels. One patient developed a pituitary tumor (initial PRL, 150 ng/ml). All patients reevaluated with brain computed tomographic scans had normal pituitary size. No patient reported a worsening of signs or symptoms, and in many, improvement (n = 16) or complete resolution (n = 8) of the amenorrhea and/or galactorrhea occurred. Twenty-seven spontaneous or bromocriptine-induced normal pregnancies and deliveries occurred without development of a pituitary tumor. Therefore, our data clearly challenge the use of ablative pituitary therapy for IH and raises questions of the benefit of chronic medical therapy for this condition.
特发性高催乳素血症(IH)可定义为患者血清催乳素(PRL)水平升高,且不存在可证实的垂体或中枢神经系统疾病以及任何其他已知的PRL分泌增加的原因。本研究对41例(平均年龄26岁)IH患者进行了长达11年(平均5.5年)的长期临床观察。初始和最终的PRL水平在同一实验室通过放射免疫分析(RIA)测定。使用了一个校正因子来消除PRL测定中所使用的美国国立卫生研究院(NIH)标准品效价的周期性变化,以便所有结果均按照最初的VLS No.1标准来表示。初始血清PRL水平范围为27.2 - 243 ng/ml,平均为57 ng/ml。只有3例患者初始血清PRL水平高于100 ng/ml。所有患者在初次就诊时颅骨X线和/或脑部计算机断层扫描均正常。41例患者均有溢乳和/或闭经。41例患者中有34例血清PRL水平保持不变、下降或恢复正常。重新评估时的平均PRL水平为35 ng/ml。34%的患者血清PRL水平正常。只有17%的患者血清PRL水平显著升高(高于其初始值的50%)。初始血清PRL水平低于40 ng/ml的9例患者中有6例水平正常。1例患者发生了垂体瘤(初始PRL为150 ng/ml)。所有接受脑部计算机断层扫描重新评估的患者垂体大小均正常。没有患者报告体征或症状恶化,许多患者的闭经和/或溢乳有所改善(n = 16)或完全缓解(n = 8)。发生了27次自然妊娠或溴隐亭诱导的正常妊娠及分娩,未出现垂体瘤。因此,我们的数据明确质疑了对IH采用垂体毁损疗法的做法,并引发了对于这种疾病进行长期药物治疗是否有益的疑问。